Science

Articles

• 3rd Edition of Translational neuroscience Day : challenges and opportunities
  4 December 2019, by Elodie DORMES

  Michel KHRESTCHATISKY co-founder of Vect-Horus – Director of the UMR7051 Institute of Neurophysiopathology at Aix-Marseille University / CNRS will speak at two sessions of The third edition of “Translational neuroscience Day: challenges and opportunities” co-organized by Dhune and hosted by BioFIT on December 10, 2019.

• Oligonucleotides for CNS Congress from February 22-24, 2021
  2 February 2021, by Elodie DORMES

  Dr Michel KHRESTCHATISKY will join the session dealing with “Exploring Extra-Hepatic Delivery to Relevant Targets within the CNS & Muscle” and give a talk to describe the use of VECT-HORUS “Molecular Vectors for Targeted Delivery of Oligonucleotides”.

• Meet Vect-Horus at 3rd Oligonucleotides for CNS Summit in Boston June 6-8th, 2023
  30 June 2023, by Elodie DORMES

  Meet with Michel KHRESTCHATISKY and Guillaume JACQUOT at the 3rd Oligonucleotides for CNS Summit 2023, dedicated to optimizing antisense and RNA chemistry for brain delivery, in Boston from June 6-8th, 2023.

• Vect-Horus will participate to the “R&D Seminar IMAGING 2022” organized by the Cerimed September 26-30, 2022
  26 September 2022, by Elodie DORMES

  VECT-HORUS S.A.S. will participate in the next event dedicated to Imaging and organized by CERIMED: “R&D Seminar IMAGING 2022” from Monday, 26th September to Friday 30th September.
  Cedric MALICET will give a talk, « From bench to Clinic », Thursday, 29th September in the workshop intitled “NUCLEAR MEDICINE Imaging”.
  It will be the occasion to present Vect-Horus technology, the last imaging results generated by in vitro and in vivo TEP with our #LDLR vectors currently in clinical study (…)

• Vect-Horus will attend the Biorezo “Nouvelles technologies de vectorisation, perspectives pour les biotechs et pharma”
  18 October 2022, by Elodie DORMES

  We are pleased to announce that Marion DAVID will be giving a talk entitled “Développement de vecteurs moléculaires pour l’adressage ciblé de molécules d’intérêt thérapeutique” during the Biorezo organized by Eurobiomed in Toulouse on October 18th.

• Vect-Horus will be attending the #EANM 2022 Annual Congress
  18 October 2022, by Elodie DORMES

  Great occasion to assist to valuable conferences about Nuclear Medicine, Molecular Imaging, Optimization of Radiolabeled Biomolecules in one of the most valuable Nuclear Medicine event in Europe.
  Meet with Cedric MALICET, PhD during the EANM on Oct 15-19, 2022 in Barcelona.

• Blood Brain Barrier Summit delivered digitally
  10 August 2020, by Elodie DORMES

  Vect-Horus will assist to the Blood Brain Barrier Summit, delivered digitally from August 31 to September 2nd, 2020

• TIDES Europe, Nov. 11-13, 2020 - 100% Virtual
  12 November 2020, by Elodie DORMES

  Dr Guillaume JACQUOT will share a presentation on “TfR-targeting VHH Nanobodies for Extra-hepatic Delivery of Oligonucleotides” a good opportunity for Vect-Horus to present its last results.
  A live Q&A session will also give the opportunity to ask questions on last trends and highlights in Oligonucleotide & Peptide Therapeutics field to expert panelists.
  TIDE is the Europe’s #1 forum for oligonucleotide and peptide leaders to build successful partnerships and accelerate new (…)

• Society for the study of Blood-Brain interfaces SEISC 2019 congres
  27 November 2019, by Elodie DORMES

  Stéphane GIRARD will present iPS cell-derived model of the human blood-brain-barrier on Friday 15, Nov Session 1 of the Society for the study of Blood-Brain interfaces SEISC 2019 congres in Paris

• TIDES Asia, March 2-5 2021 - 100% Virtual
  4 March 2021, by Elodie DORMES

  Guillaume JACQUOT PharmD, PhD, will present last company results on extra-hepatic delivery of oligonucleotides.